Cotadutide (MEDI0382) is the most extensively developed dual GLP-1/glucagon receptor agonist, showing significant improvements in glucose control, BW (likely mediated by reduced energy intake rather than increased energy expenditure), hepatic fat, and albuminuria in a small RCT on patients with T2D and overweight or obesity 45,46
Lets help your body remember how to heal, balance, and thrive
Sorry, the comment form is closed at this time.
Supports healthy aging: NMN supplements can potentially slow age-related decline by increasing NAD+ levels, which assist in DNA repair, cellular metabolism, and energy production
The evidence base for Lipo C in weight loss remains weak, while tirzepatide's benefit is robust and dose-adjustable
Administering the peptide at night aligns with this rhythm, producing a compounded effect